Pharsight

1. Drug name - BEVYXXA

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7598276	PORTOLA PHARMS INC	Pharmaceutical salts and polymorphs of a factor Xa inhibitor	Nov, 2026 (4 years from now)
CN102336702A	PORTOLA PHARMS INC	Xa Factor Inhibitor N-(5-Chloro--2-Pyridyl)--2-[[4-[(Dimethylamino) Methyl] Benzoyl] Amino]--5-Methoxy-Benzamide Of Pharmaceutical Salt And Polymorph	Nov, 2026 (4 years from now)
CN101304971B	PORTOLA PHARMS INC	Xa Factor Inhibitor N-(5-Chloro--2-Pyridyl)--2-[[4-[(Dimethylamino) Methyl] Benzoyl] Amino]--5-Methoxy-Benzamide Of Pharmaceutical Salt And Polymorph	Nov, 2026 (4 years from now)
CN102336702B	PORTOLA PHARMS INC	Xa Factor Inhibitor N - (5-Dichloro - -2 - Pyridyl)--2-[[4 - [(Dimethylamino) Iminomethyl] Benzoyl] Amino] -5 - Benzamide Of Pharmaceutical Salts And Polymorphs	Nov, 2026 (4 years from now)
CN101304971A	PORTOLA PHARMS INC	Pharmaceutical Salts And Polymorphs Of A Factor Xa Inhibitor N-(5-Chloro-2- Pyridyl)-2-[[4-[(Dimethylamino)Iminomethyl]Benzoyl]Amino]-5-Methoxy-Benzamide	Nov, 2026 (4 years from now)
IN201400546P2	PORTOLA PHARMS INC	Method Of Making A Factor Xa Inhibitor	Nov, 2026 (4 years from now)
IN319923B	PORTOLA PHARMS INC	Method Of Making A Factor Xa Inhibitor	Nov, 2026 (4 years from now)
EP1948608A2	PORTOLA PHARMS INC	Pharmaceutical Salts And Polymorphs Of N-(5-Chloro-2-Pyridinyl)-2-[[4-[(Dimethylamino)Iminomethyl]Benzoyl]Amino]-5-Methoxy-Benzamide , A Factor Xa Inhibitor	Nov, 2026 (4 years from now)
EP1948608B1	PORTOLA PHARMS INC	Pharmaceutical Salts And Polymorphs Of N-(5-Chloro-2-Pyridinyl)-2-[[4-[(Dimethylamino)Iminomethyl]Benzoyl]Amino]-5-Methoxy-Benzamide , A Factor Xa Inhibitor	Nov, 2026 (4 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9555023	PORTOLA PHARMS INC	Pharmaceutical salts and polymorphs of a factor Xa inhibitor	Nov, 2026 (4 years from now)
US8557852	PORTOLA PHARMS INC	Methods of using crystalline forms of a salt of a factor Xa inhibitor	Sep, 2028 (5 years from now)
US8987463	PORTOLA PHARMS INC	Methods of synthesizing factor Xa inhibitors	Dec, 2030 (8 years from now)
US8404724	PORTOLA PHARMS INC	Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor	Mar, 2031 (8 years from now)

Treatment: Prophylaxis of pulmonary embolism; Prophylaxis of deep vein thrombosis (dvt); prophylaxis of venous thrombosis; Inhibiting coagulation

Dosage: CAPSULE;ORAL

Strength	Dosage	Availability
40MG	CAPSULE;ORAL	Discontinued
80MG	CAPSULE;ORAL	Discontinued

availability in other generic markets.

Click on the highlighted region to filter.